HIGHLIGHTS
- who: Kayo Suzuki from the Department of, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Nu201115, Wu20117, Kitau2011Ku, Sapporo, u20118638, Japan have published the research: Clinical significance of serum and vitreous soluble interleukin-2 receptor in patients with intraocular lymphoma, in the Journal: (JOURNAL)
- what: The aim of this study was to review the reliability of serum and vitreous sIL-2R for distinguishing IOL from uveitis.
- how: This study was conducted in accordance with the guidelines of the Declaration of Helsinki and approved by the institutional review boards of Hokkaido University . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.